Concert Pharmaceuticals Inc 's

Name: Concert Pharmaceuticals Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CNCE Sales vs. its Competitors Q3 2022

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Concert Pharmaceuticals Inc recorded a net loss, as well as most of its competitors.

<< CNCE Stock Performance Comparisons

<< See the full list of CNCE competitors

*Market share is calculated based on total revenue.

CNCE's Stock Performance relative to its Competitors

Publicly Traded Peers of Concert Pharmaceuticals Inc

Cadrenal Therapeutics Inc
Share Performance

-76.13%

This Year

Cadrenal Therapeutics Inc

Profile

Cadrenal Therapeutics Inc's business model revolves around the development and commercialization of innovative therapies in the field of renal diseases.

More about Cadrenal Therapeutics Inc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 3.489 mill.	$ - mill.	$ -14.206 mill.

Sources: Concert Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, July 6, 2026 7:33 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Concert Pharmaceuticals Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.